GLEN ALLEN, Va., Jan. 2, 2014 /PRNewswire/ -- Star Scientific, Inc., (NASDAQ: STSI) announced today that the Company will hold a conference call for investors on January 15, 2014, to discuss recent developments and the Company's plans going forward. In addition, an investor meeting, which was first referenced in a press release issued on November 7, 2013, will be held in Sarasota, Florida, in the first quarter. A dial-in number for the January 15 meeting, along with other details, will be provided as the meeting date approaches.
In commenting on the conference call and the investor meeting, the Company's newly elected Chairman and CEO, Michael J. Mullan, MBBS (M.D.), PhD, stated, "Dr. Chris Chapman, the Board of Directors, and I are committed to transparency in our communications with the Company's shareholders. We look forward to the conference call and investor meeting which will provide an opportunity for us to interact with shareholders and investors."
Certain statements contained in this release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to statements identified by words such as "believes," "expects," "anticipates," "estimates," "intends," "plans," "targets," "projects" and similar expressions. The statements in this release are based upon the current beliefs and expectations of our company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. Numerous factors could cause or contribute to such differences, including, but not limited to, results of clinical trials and/or other studies, the challenges inherent in new product development initiatives, including the continued development and market acceptance of our nutraceutical dietary supplements products, the effect of any competitive products, our ability to license and protect our intellectual property, our ability to raise additional capital in the future that is necessary to maintain our business, changes in government policy and/or regulation, potential litigation by or against us, any governmental review of our products or practices and the outcome of the ongoing investigations as well as other risks discussed from time to time in our filings with the Securities and Exchange Commission, including, without limitation, our annual report on Form 10-K for the fiscal year ended December 31, 2012 and our quarterly reports on Form 10-Q for the quarters ended March 31, 2013, June 30, 2013, and September 30, 2013. We undertake no duty to update any forward-looking statement or any information contained in this press release or in other public disclosures at any time.
Contact: Talhia T. Tuck Vice President, Communications and Investor Relations Star Scientific, Inc. (202)887-5100 firstname.lastname@example.orgSOURCE Star Scientific, Inc.